365 related articles for article (PubMed ID: 12649186)
41. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
42. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
43. Insufficient accumulation of viral late mRNAs restricts the replicative cycle of human adenovirus type 37 in A549 cells.
Adachi K; Mitani K
Arch Virol; 2009; 154(9):1401-7. PubMed ID: 19609636
[TBL] [Abstract][Full Text] [Related]
44. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
[TBL] [Abstract][Full Text] [Related]
45. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
[TBL] [Abstract][Full Text] [Related]
46. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
Routes JM
J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
[TBL] [Abstract][Full Text] [Related]
47. An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice.
Nakayama M; Both GW; Banizs B; Tsuruta Y; Yamamoto S; Kawakami Y; Douglas JT; Tani K; Curiel DT; Glasgow JN
Virology; 2006 Jun; 350(1):103-15. PubMed ID: 16516257
[TBL] [Abstract][Full Text] [Related]
48. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
Hoffmann D; Wildner O
Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
[TBL] [Abstract][Full Text] [Related]
49. Dependence of adenovirus infectivity on length of the fiber shaft domain.
Shayakhmetov DM; Lieber A
J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
[TBL] [Abstract][Full Text] [Related]
50. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.
Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT
Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580
[TBL] [Abstract][Full Text] [Related]
51. Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.
Leja J; Yu D; Nilsson B; Gedda L; Zieba A; Hakkarainen T; Åkerström G; Öberg K; Giandomenico V; Essand M
Gene Ther; 2011 Nov; 18(11):1052-62. PubMed ID: 21490682
[TBL] [Abstract][Full Text] [Related]
52. Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.
Douglas JT; Kim M; Sumerel LA; Carey DE; Curiel DT
Cancer Res; 2001 Feb; 61(3):813-7. PubMed ID: 11221860
[TBL] [Abstract][Full Text] [Related]
53. Improved adenovirus vectors for infection of cardiovascular tissues.
Havenga MJ; Lemckert AA; Grimbergen JM; Vogels R; Huisman LG; Valerio D; Bout A; Quax PH
J Virol; 2001 Apr; 75(7):3335-42. PubMed ID: 11238859
[TBL] [Abstract][Full Text] [Related]
54. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
55. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses.
Shayakhmetov DM; Li ZY; Ternovoi V; Gaggar A; Gharwan H; Lieber A
J Virol; 2003 Mar; 77(6):3712-23. PubMed ID: 12610146
[TBL] [Abstract][Full Text] [Related]
56. Altered tropism of an ovine adenovirus carrying the fiber protein cell binding domain of human adenovirus type 5.
Xu ZZ; Both GW
Virology; 1998 Aug; 248(1):156-63. PubMed ID: 9705265
[TBL] [Abstract][Full Text] [Related]
57. Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners.
Yu L; Shimozato O; Li Q; Kawamura K; Ma G; Namba M; Ogawa T; Kaiho I; Tagawa M
Anticancer Res; 2007; 27(4B):2311-6. PubMed ID: 17695519
[TBL] [Abstract][Full Text] [Related]
58. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.
Leissner P; Legrand V; Schlesinger Y; Hadji DA; van Raaij M; Cusack S; Pavirani A; Mehtali M
Gene Ther; 2001 Jan; 8(1):49-57. PubMed ID: 11402301
[TBL] [Abstract][Full Text] [Related]
59. Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor.
Lenaerts L; Daelemans D; Geukens N; De Clercq E; Naesens L
FEBS Lett; 2006 Jul; 580(16):3937-42. PubMed ID: 16806202
[TBL] [Abstract][Full Text] [Related]
60. Fiber-substituted conditionally replicating adenovirus for oncolysis of human renal carcinoma cells.
Nagaya H; Tagawa M; Hiwasa K; Terao S; Kanno T; Nishizaki T; Gotoh A
Anticancer Res; 2012 Jul; 32(7):2985-9. PubMed ID: 22753762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
